Skip to main content
logo
Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
19.86
+0.45 (2.29%)
Sep 3, 2026, 1:04 PM EDT - Market open

Beta Bionics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
119.01100.2565.12120.18
Revenue Growth
52.54%53.94%442.93%6601.12%-
Gross Profit
69.455.5435.896.310.18
Operating Income
-83.02-71.68-45.25-35.85-64.74
Net Income
-72.97-73.2-54.76-44.1-64.75
Earnings Per Share
-1.65-1.81-8.60-8.31-12.96
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
180.49219.13103.5896.7527.68
Total Debt
6.517.37.264.224.13
Net Cash (Debt)
173.98211.8296.3292.5223.54
Net Cash Growth
-28.41%119.91%4.11%293.01%-
Net Cash Per Share
3.935.2315.1317.444.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-55.81-50.93-48.27-32.45-60.21
Capital Expenditures
-5.6-5.3-3.4-0.4-0.77
Free Cash Flow
-61.41-56.22-51.67-32.85-60.98
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
58.31%55.40%55.11%52.59%100.00%
Operating Margin
-69.75%-71.50%-69.48%-298.88%-36169.83%
Pretax Margin
-61.32%-73.02%-84.08%-367.64%-36173.74%
Profit Margin
-61.31%-73.02%-84.08%-367.64%-36173.74%
FCF Margin
-51.60%-56.08%-79.34%-273.84%-34067.04%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
7.3413.38---